Functional Mutation of Multiple Solvent-Exposed Loops in the Ecballium elaterium Trypsin Inhibitor-II Cystine Knot Miniprotein Engineering Multiple Loops in EETI-II
2011

Engineering a Miniprotein for Tumor Imaging

Sample size: 3 publication 10 minutes Evidence: moderate

Author Information

Author(s): Kimura Richard H., Jones Douglas S., Jiang Lei, Miao Zheng, Cheng Zhen, Cochran Jennifer R.

Primary Institution: Stanford University

Hypothesis

Can the Ecballium elaterium trypsin inhibitor (EETI-II) be engineered to enhance binding to tumor-associated integrin receptors?

Conclusion

The study successfully engineered a knottin peptide that binds with high affinity to tumor-associated integrin receptors, showing potential for non-invasive imaging.

Supporting Evidence

  • The engineered knottin peptide showed high affinity binding to αvβ3 and αvβ5 integrins.
  • IC50 values for the knottin peptides were determined in the low nanomolar range.
  • A radiolabeled version demonstrated favorable tumor-to-muscle and tumor-to-blood ratios.
  • Binding assays confirmed the specificity of the engineered peptides for integrin receptors.

Takeaway

Scientists made a tiny protein that can stick to cancer cells, helping doctors see tumors better using special imaging.

Methodology

Yeast surface display was used to engineer an EETI-II mutant with two integrin binding loops, followed by binding affinity and specificity assays.

Limitations

Reduced serum and metabolic stability were observed compared to previous EETI-II variants.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016112

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication